2017
DOI: 10.1097/rhu.0000000000000410
|View full text |Cite
|
Sign up to set email alerts
|

Rheumatoid Arthritis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…24 However, rheumatologists preferred to prescribe combination therapy rather than monotherapy because of the increased efficacy and enhanced improvement of the patient over time. 5 Dell et al performed a two years study and measured the difference in the improvement of patients with three different treatments i.e, Methotrexate (MXT) alone, Sulfasalazine (SFS) and Hydroxychloroquine (HCQ) combined treatment and combination of all three. The combined treatment of MXT, SFS and HCQ, called triple therapy is found to be an effective treatment that increases efficacy without an increase in the toxicity when compared to gold standard treatment of MXT alone.…”
Section: Introductionmentioning
confidence: 99%
“…24 However, rheumatologists preferred to prescribe combination therapy rather than monotherapy because of the increased efficacy and enhanced improvement of the patient over time. 5 Dell et al performed a two years study and measured the difference in the improvement of patients with three different treatments i.e, Methotrexate (MXT) alone, Sulfasalazine (SFS) and Hydroxychloroquine (HCQ) combined treatment and combination of all three. The combined treatment of MXT, SFS and HCQ, called triple therapy is found to be an effective treatment that increases efficacy without an increase in the toxicity when compared to gold standard treatment of MXT alone.…”
Section: Introductionmentioning
confidence: 99%